Substance evaluation - CoRAP
Substance evaluation - CoRAP
For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.
Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.
Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.
- Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
- The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
- When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
- When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
- Contact details of the evaluating Member States are provided for all the substance included.
- Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.
Legend:
- Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
- CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
- Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
- Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
- Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
- RCR: Risk Characterisation Ratio
Last updated 13 December 2019. Database contains 375 unique substances/entries.
242-060-2 | 18172-67-3 | 2014 | Greece | Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
247-156-8 | 25640-78-2 | Germany | Suspected PBT/vPvB Wide dispersive use | Not started | Details | ||
284-366-9 | 84852-53-9 | 2012 | Sweden | Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
306-832-3 | 97416-84-7 | 2017 | Germany | Potential endocrine disruptor Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
244-617-5 | 21850-44-2 | 2017 | Germany | Potential endocrine disruptor Suspected PBT/vPvB High (aggregated) tonnage | Ongoing | Details | |
203-820-9 | 110-97-4 | 2013 | Czech Republic | Suspected CMR Suspected Sensitiser Consumer use Exposure of workers High RCR Wide dispersive use | Concluded | Details | |
213-668-5 | 999-97-3 | 2014 | Spain | High (aggregated) tonnage High RCR | Concluded | Details | |
241-867-7 | 17928-28-8 | 2020 | Norway | Suspected PBT/vPvB Wide dispersive use | Not started | Details | |
217-496-1 | 1873-88-7 | 2020 | Norway | Suspected PBT/vPvB | Not started | Details | |
206-022-9 | 288-88-0 | 2015 | Belgium | Suspected CMR Other hazard based concern Exposure of environment High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use | Ongoing | Details | |
271-082-5 | 68515-40-2 | 2014 | Denmark | Suspected CMR High (aggregated) tonnage Other exposure/risk based concern | Information requested | Details | |
700-989-5 | - | 2014 | Denmark | Suspected CMR High (aggregated) tonnage Other exposure/risk based concern | Ongoing | Details | |
271-089-3 | 68515-47-9 | 2014 | Denmark | High (aggregated) tonnage Other exposure/risk based concern Suspected CMR | Ongoing | Details | |
271-085-1 | 68515-43-5 | 2014 | Denmark | Suspected CMR High (aggregated) tonnage Other exposure/risk based concern | Ongoing | Details | |
202-425-9 | 95-50-1 | 2013 | Hungary | Suspected CMR High (aggregated) tonnage Wide dispersive use | Conclusion under preparation | Details | |
203-812-5 | 110-88-3 | 2013 | Poland | Suspected CMR Suspected PBT/vPvB Suspected Sensitiser Exposure of environment High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
219-514-3 | 2451-62-9 | 2015 | Poland | CMR Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers Wide dispersive use | Concluded | Details | |
203-308-5 | 105-55-5 | 2019 | Poland | Suspected Carcinogenic Suspected Sensitiser Consumer use Exposure of environment Exposure of workers Wide dispersive use | Ongoing | Details | |
258-904-8 | 53988-10-6 | 2018 | Germany | Potential endocrine disruptor Exposure of environment | Ongoing | Details | |
262-872-0 | 61617-00-3 | 2018 | Germany | Potential endocrine disruptor Exposure of environment | Ongoing | Details | |
202-773-1 | 99-62-7 | 2020 | Bulgaria | Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers | Not started | Details | |
211-463-5 | 646-06-0 | 2016 | Germany | Suspected Mutagenic Suspected Reprotoxic Consumer use Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
203-002-1 | 102-06-7 | 2012 | France | CMR High (aggregated) tonnage High RCR | Ongoing | Details | |
204-077-3 | 115-27-5 | 2013 | France | CMR Suspected PBT/vPvB Suspected Sensitiser Exposure of environment Exposure of workers | Information requested | Details | |
273-227-8 | 68953-84-4 | 2013 | Germany | Suspected PBT/vPvB Consumer use High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
202-826-9 | 100-18-5 | 2020 | Bulgaria | Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers | Not started | Details | |
627-083-1 | 244235-47-0 | 2015 | Spain | Suspected PBT/vPvB High (aggregated) tonnage | Concluded | Details | |
219-372-2 | 2425-85-6 | 2019 | Germany | Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
EC No. 216-133-4 and EC No. 244-240-6 show/hide 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7 | - | - | 2020 | Germany | Potential endocrine disruptor High (aggregated) tonnage | Not started | Details |
222-429-4 | 3468-63-1 | 2019 | Germany | Suspected Carcinogenic Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers Wide dispersive use | Ongoing | Details | |
220-562-2 | 2814-77-9 | 2019 | Germany | Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
274-581-6 | 70356-09-1 | 2015 | Germany | Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
216-475-4 | 1594-08-7 | 2019 | Belgium | Suspected PBT/vPvB | Ongoing | Details | |
701-029-8 | - | Estonia | CMR Sensitiser Consumer use Wide dispersive use | Not started | Details | ||
202-707-1 | 98-85-1 | 2019 | Italy | Suspected Carcinogenic Suspected Mutagenic Consumer use Exposure of workers Wide dispersive use | Ongoing | Details | |
700-604-0 | 947701-81-7 | Finland | Suspected PBT/vPvB Consumer use | Not started | Details | ||
203-049-8 | 102-71-6 | 2014 | United Kingdom | Suspected CMR Suspected Sensitiser Other hazard based concern Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
926-564-6 | - | 2016 | Germany | Potential endocrine disruptor Suspected PBT/vPvB Exposure of environment | Information requested | Details | |
216-823-5 | 1675-54-3 | 2015 | Denmark | Suspected CMR Potential endocrine disruptor Consumer use High (aggregated) tonnage Wide dispersive use | Follow-up | Details | |
229-962-1 | 6864-37-5 | 2015 | Germany | Potential endocrine disruptor | Ongoing | Details | |
203-868-0 | 111-42-2 | 2012 | Germany | Suspected CMR High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
203-312-7 | 105-59-9 | 2013 | United Kingdom | Suspected CMR High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
203-872-2 | 111-46-6 | 2015 | Hungary | Suspected CMR Other hazard based concern Consumer use High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
201-236-9 | 79-94-7 | 2015 | Denmark | Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
253-057-0 | 36483-57-5 | 2021 | Denmark | Suspected Carcinogenic Suspected Mutagenic | Not started | Details | |
204-279-1 | 118-82-1 | 2014 | Austria | Suspected CMR Potential endocrine disruptor Suspected PBT/vPvB Suspected Sensitiser Consumer use Exposure of environment Exposure of workers Wide dispersive use | Information requested | Details | |
247-979-2 | 26761-45-5 | 2015 | Denmark | Suspected CMR Suspected Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Follow-up | Details | |
218-645-3 | 2210-79-9 | 2016 | Denmark | Mutagenic | Information requested | Details | |
211-989-5 | 732-26-3 | 2017 | Belgium | Suspected PBT/vPvB Exposure of environment | Concluded | Details | |
204-278-6 | 118-79-6 | 2012 | Norway | CMR Suspected PBT/vPvB High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
203-614-9 | 108-77-0 | 2017 | Poland | Suspected Reprotoxic Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage | Concluded | Details | |
202-532-0 | 96-76-4 | 2017 | Belgium | Suspected CMR Potential endocrine disruptor Consumer use Wide dispersive use | Information requested | Details | |
249-820-2 | 29736-75-2 | 2018 | Germany | Suspected Carcinogenic Suspected Reprotoxic Other hazard based concern Exposure of workers | Ongoing | Details | |
201-222-2 | 79-74-3 | 2014 | Italy | Suspected PBT/vPvB High RCR | Follow-up | Details | |
622-542-2 | 3891-98-3 | 2020 | Austria | Suspected Mutagenic Suspected PBT/vPvB Suspected Sensitiser Consumer use Exposure of environment Exposure of workers | Not started | Details | |
204-881-4 | 128-37-0 | 2016 | France | Potential endocrine disruptor Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
226-866-1 | 5521-31-3 | 2021 | Belgium | Suspected PBT/vPvB | Not started | Details | |
200-076-7 | 51-03-6 | Sweden | Potential endocrine disruptor Suspected PBT/vPvB Consumer use Wide dispersive use | Not started | Details | ||
219-470-5 | 2440-22-4 | 2016 | Czech Republic | Sensitiser Consumer use Exposure of workers High RCR Wide dispersive use | Concluded | Details | |
201-289-8 | 80-54-6 | 2012 | Sweden | CMR Consumer use Wide dispersive use | Ongoing | Details | |
405-490-3 | 613-62-7 | 2012 | Czech Republic | Other hazard based concern High (aggregated) tonnage | Concluded | Details | |
228-768-4 | 6358-31-2 | 2019 | Italy | Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
229-355-1 | 6486-23-3 | 2019 | Italy | Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
229-419-9 | 6528-34-3 | 2019 | Italy | Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
1 - 4.5 moles ethoxylated | 500-082-2 | 32492-61-8 | 2021 | France | Suspected Mutagenic Potential endocrine disruptor Exposure of environment High (aggregated) tonnage Wide dispersive use | Not started | Details |
266-733-5 | 67584-55-8 | 2018 | Germany | Suspected PBT/vPvB Other hazard based concern Exposure of environment Wide dispersive use | Concluded | Details | |
205-483-3 | 141-43-5 | 2014 | United Kingdom | Suspected Sensitiser High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
627-872-0 | 1514-82-5 | 2019 | Spain | Suspected Reprotoxic Potential endocrine disruptor | Ongoing | Details | |
484-410-9 | - | 2019 | Spain | Suspected PBT/vPvB | Ongoing | Details | |
239-701-3 | 15625-89-5 | 2014 | France | Sensitiser Exposure of workers High RCR Wide dispersive use | Concluded | Details | |
203-234-3 | 104-76-7 | 2014 | Poland | Suspected CMR Consumer use High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
205-743-6 | 149-57-5 | 2012 | Spain | CMR Consumer use High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
248-227-6 | 27107-89-7 | 2021 | Netherlands | Potential endocrine disruptor | Not started | Details | |
260-828-5 | 57583-34-3 | 2015 | Netherlands | CMR High (aggregated) tonnage | Suspended | Details | |
203-079-1 | 103-09-3 | 2015 | Belgium | Suspected CMR Consumer use Wide dispersive use | Concluded | Details | |
204-263-4 | 118-60-5 | 2020 | Germany | Potential endocrine disruptor | Not started | Details | |
629-661-9 | 83834-59-7 | 2016 | Germany | Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use | Information requested | Details | |
202-627-7 | 98-01-1 | 2021 | Denmark | Suspected Carcinogenic Suspected Mutagenic Exposure of workers High (aggregated) tonnage Wide dispersive use | Not started | Details | |
212-782-2 | 868-77-9 | 2014 | France | Suspected CMR Sensitiser Consumer use High (aggregated) tonnage High RCR Wide dispersive use | Ongoing | Details | |
200-889-7 | 75-65-0 | 2013 | United Kingdom | Suspected CMR Consumer use High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
202-112-7 | 91-97-4 | 2013 | France | Suspected CMR Suspected PBT/vPvB Sensitiser Consumer use | Concluded | Details | |
241-527-8 | 17527-29-6 | 2016 | Germany | Potential endocrine disruptor Suspected PBT/vPvB Other hazard based concern Exposure of environment Wide dispersive use | Information requested | Details | |
218-407-9 | 2144-53-8 | 2016 | Germany | Potential endocrine disruptor Suspected PBT/vPvB Other hazard based concern Exposure of environment Wide dispersive use | Information requested | Details | |
201-126-0 | 78-59-1 | 2013 | France | CMR Exposure of workers High (aggregated) tonnage Wide dispersive use | Follow-up | Details | |
221-975-0 | 3302-10-1 | 2020 | Spain | Suspected Reprotoxic Exposure of workers | Not started | Details | |
200-657-5 | 67-51-6 | 2020 | Spain | Reprotoxic High RCR | Not started | Details | |
242-016-2 | 18127-01-0 | 2020 | Sweden | Suspected Reprotoxic Consumer use Exposure of workers Wide dispersive use | Not started | Details | |
432-520-2 | 232938-43-1 | 2020 | Belgium | Suspected Reprotoxic Potential endocrine disruptor | Not started | Details | |
203-680-9 | 109-55-7 | 2014 | Austria | Sensitiser Exposure of workers High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
435-790-1 | 297730-93-9 | 2018 | Spain | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Ongoing | Details | |
264-727-7 | 64194-22-5 | 2021 | Slovenia | Suspected Carcinogenic Exposure of workers Wide dispersive use | Not started | Details | |
204-633-5 | 123-51-3 | 2020 | Poland | Suspected Carcinogenic Suspected Reprotoxic Suspected Sensitiser Consumer use Exposure of workers | Not started | Details | |
215-925-7 | 1453-58-3 | 2018 | Belgium | Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Wide dispersive use | Ongoing | Details | |
219-785-8 | 2530-85-0 | 2015 | Ireland | Suspected Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Follow-up | Details | |
201-052-9 | 77-73-6 | 2016 | France | Suspected Reprotoxic Exposure of workers High (aggregated) tonnage High RCR | Ongoing | Details | |
428-970-4 | 13595-25-0 | 2014 | Belgium | Suspected PBT/vPvB Other hazard based concern Consumer use Exposure of environment | Concluded | Details | |
253-781-7 | 38103-06-9 | 2013 | Germany | Suspected PBT/vPvB High (aggregated) tonnage | Concluded | Details | |
Bisphenol A; BPA | 201-245-8 | 80-05-7 | 2012 | Germany | Potential endocrine disruptor Consumer use High (aggregated) tonnage Wide dispersive use | Concluded | Details |
233-593-1 | 10254-57-6 | 2020 | Germany | Suspected PBT/vPvB | Not started | Details | |
249-204-3 | 28768-32-3 | 2013 | Denmark | CMR Wide dispersive use | Information requested | Details | |
701-276-1 | - | Estonia | CMR Suspected PBT/vPvB Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use | Not started | Details | ||
1 - 4.5 moles propoxylated | 500-097-4 | 37353-75-6 | 2013 | Denmark | Suspected CMR High (aggregated) tonnage Wide dispersive use | Conclusion under preparation | Details |
201-250-5 | 80-09-1 | 2014 | Belgium | Suspected CMR Potential endocrine disruptor High (aggregated) tonnage | Information requested | Details | |
202-966-0 | 101-68-8 | 2013 | Estonia | CMR Suspected PBT/vPvB Sensitiser Consumer use Wide dispersive use | Concluded | Details | |
405-520-5 | 95235-30-6 | 2021 | Belgium | Potential endocrine disruptor Other exposure/risk based concern | Not started | Details | |
202-804-9 | 99-96-7 | 2014 | Czech Republic | Suspected CMR Potential endocrine disruptor Consumer use High (aggregated) tonnage | Concluded | Details | |
203-253-7 | 104-93-8 | 2012 | Ireland | CMR Consumer use High RCR Wide dispersive use | Concluded | Details | |
202-679-0 | 98-54-4 | 2014 | Germany | Potential endocrine disruptor High (aggregated) tonnage | Ongoing | Details | |
202-653-9 | 98-29-3 | 2018 | Poland | Suspected Mutagenic Potential endocrine disruptor Suspected PBT/vPvB Sensitiser Exposure of environment Exposure of workers | Concluded | Details | |
204-327-1 | 119-47-1 | 2016 | Denmark | Suspected Reprotoxic Potential endocrine disruptor | Concluded | Details | |
201-618-5 | 85-60-9 | 2019 | France | Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers Wide dispersive use | Ongoing | Details | |
202-525-2 | 96-69-5 | 2015 | Austria | Suspected CMR Potential endocrine disruptor Suspected PBT/vPvB Sensitiser Consumer use Wide dispersive use | Information requested | Details | |
219-207-4 | 2386-87-0 | 2013 | Ireland | Suspected CMR Sensitiser Exposure of workers High RCR | Concluded | Details | |
246-678-3 | 25155-25-3 | 2015 | Netherlands | Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
251-020-3 | 32388-55-9 | 2021 | Netherlands | Potential endocrine disruptor Suspected PBT/vPvB | Not started | Details | |
422-040-1 | 426218-78-2 | 2016 | Spain | Suspected PBT/vPvB Exposure of environment High RCR | Information requested | Details | |
405-040-6 | 63500-71-0 | 2012 | Spain | High RCR Wide dispersive use | Concluded | Details | |
458-680-3 | 797751-44-1 | 2019 | Spain | Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
421-820-9 | 192268-65-8 | 2020 | Netherlands | Suspected PBT/vPvB | Not started | Details | |
283-044-5 | 84539-55-9 | 2020 | Sweden | Suspected Reprotoxic Potential endocrine disruptor Suspected Sensitiser Consumer use Exposure of environment Exposure of workers Wide dispersive use | Not started | Details | |
204-820-1 | 127-06-0 | 2016 | Austria | Suspected Carcinogenic Suspected Mutagenic Suspected Sensitiser Exposure of environment Exposure of workers High RCR Wide dispersive use | Concluded | Details | |
247-118-0 | 25584-83-2 | 2021 | France | Suspected Carcinogenic Suspected Mutagenic Suspected Sensitiser Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use | Not started | Details | |
271-231-4 | 68526-83-0 | 2016 | Italy | Suspected Carcinogenic Suspected Mutagenic Consumer use Exposure of workers Wide dispersive use | Concluded | Details | |
287-477-0 | 85535-85-9 | 2012 | Sweden | Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
231-208-1 | 7446-70-0 | 2015 | France | Suspected CMR Exposure of workers High (aggregated) tonnage High RCR | Information requested | Details | |
215-477-2 | 1327-41-9 | 2015 | France | Suspected CMR High (aggregated) tonnage | Information requested | Details | |
233-135-0 | 10043-01-3 | 2015 | France | Suspected CMR Suspected Sensitiser Consumer use High (aggregated) tonnage High RCR Wide dispersive use | Information requested | Details | |
800-353-8 | 1379524-06-7 | 2016 | Germany | Suspected PBT/vPvB Other hazard based concern Exposure of environment High RCR Wide dispersive use | Concluded | Details | |
931-292-6 | 308062-28-4 | 2020 | Ireland | Suspected Reprotoxic Other hazard based concern | Not started | Details | |
480-310-4 | - | 2017 | Germany | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Ongoing | Details | |
700-242-3 | 62037-80-3 | 2017 | Germany | Suspected PBT/vPvB Exposure of environment | Information requested | Details | |
700-323-3 | 908020-52-0 | 2017 | Germany | Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
232-235-1 | 7790-98-9 | 2015 | Germany | Suspected Carcinogenic Potential endocrine disruptor Other hazard based concern Exposure of workers High RCR Wide dispersive use | Concluded | Details | |
700-403-8 | - | 2013 | Belgium | Suspected PBT/vPvB Consumer use Wide dispersive use | Ongoing | Details | |
217-175-6 | 1762-95-4 | 2015 | Czech Republic | Suspected CMR Potential endocrine disruptor High (aggregated) tonnage High RCR Wide dispersive use | Concluded | Details | |
- | - | 2018 | Belgium | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Ongoing | Details | |
232-565-6 | 9000-90-2 | 2015 | United Kingdom | Sensitiser Consumer use Exposure of workers | Concluded | Details | |
231-146-5 | 7440-36-0 | 2018 | Germany | Suspected Carcinogenic Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use | Ongoing | Details | |
215-713-4 | 1345-04-6 | 2018 | Germany | Suspected Carcinogenic Exposure of workers High RCR Other exposure/risk based concern Wide dispersive use | Ongoing | Details | |
233-047-2 | 10025-91-9 | 2018 | Germany | Suspected Carcinogenic Suspected Reprotoxic | Concluded | Details | |
225-935-3 | 5160-02-1 | 2020 | Germany | Suspected Carcinogenic Exposure of workers Wide dispersive use | Not started | Details | |
202-860-4 | 100-52-7 | 2020 | France | Suspected Mutagenic Consumer use Exposure of workers Wide dispersive use | Not started | Details | |
270-128-1 | 68411-46-1 | 2016 | Germany | Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
309-912-6 | 101357-15-7 | 2019 | Germany | Suspected PBT/vPvB | Ongoing | Details | |
284-660-7 | 84961-70-6 | 2014 | Italy | Consumer use High (aggregated) tonnage Suspected PBT/vPvB Wide dispersive use | Information requested | Details | |
810-801-4 | - | 2015 | Netherlands | Suspected CMR Suspected PBT/vPvB High (aggregated) tonnage | Ongoing | Details | |
204-337-6 | 119-61-9 | 2013 | Denmark | Suspected CMR Consumer use High RCR Wide dispersive use | Concluded | Details | |
205-736-8 | 149-30-4 | 2013 | Germany | CMR Sensitiser Consumer use Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
202-394-1 | 95-14-7 | 2016 | Germany | Potential endocrine disruptor Exposure of environment | Information requested | Details | |
202-859-9 | 100-51-6 | 2016 | Germany | Suspected Sensitiser Exposure of workers High RCR Wide dispersive use | Follow-up | Details | |
204-262-9 | 118-58-1 | 2020 | Germany | Potential endocrine disruptor | Not started | Details | |
231-150-7 | 7440-41-7 | 2013 | Germany | Other exposure/risk based concern | Concluded | Details | |
931-700-2 | - | 2021 | France | Suspected Reprotoxic Other hazard based concern Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use | Not started | Details | |
202-163-5 | 92-52-4 | 2013 | Portugal | Suspected PBT/vPvB High (aggregated) tonnage | Conclusion under preparation | Details | |
218-487-5 | 2162-74-5 | 2021 | Italy | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Not started | Details | |
421-450-8 | 154702-15-5 | 2015 | Germany | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Information requested | Details | |
203-090-1 | 103-23-1 | 2020 | Finland | Suspected CMR Consumer use High (aggregated) tonnage Wide dispersive use | Not started | Details | |
247-426-5 | 26040-51-7 | 2019 | Sweden | Potential endocrine disruptor Suspected PBT/vPvB Other hazard based concern Exposure of environment Wide dispersive use | Ongoing | Details | |
203-372-4 | 106-20-7 | 2019 | Portugal | Suspected PBT/vPvB Exposure of environment | Ongoing | Details | |
258-469-4 | 53306-54-0 | 2020 | Germany | Potential endocrine disruptor Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use | Not started | Details | |
201-247-9 | 80-07-9 | 2019 | Austria | Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
237-695-7 | 13927-71-4 | 2020 | France | Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Exposure of workers | Not started | Details | |
254-052-6 | 38640-62-9 | 2013 | Sweden | Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use | Information requested | Details | |
700-183-3 | 52299-25-9 | 2018 | Germany | Suspected PBT/vPvB Other hazard based concern Exposure of environment | Concluded | Details | |
253-249-4 | 36878-20-3 | 2020 | France | Suspected Mutagenic Suspected PBT/vPvB High (aggregated) tonnage | Not started | Details | |
243-001-3 | 19372-44-2 | 2015 | Germany | Sensitiser Other hazard based concern Exposure of workers High (aggregated) tonnage | Ongoing | Details | |
201-279-3 | 80-43-3 | 2015 | Norway | Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use | Information requested | Details | |
203-450-8 | 106-99-0 | 2014 | Germany | CMR Other exposure/risk based concern | Concluded | Details | |
200-751-6 | 71-36-3 | 2017 | Hungary | Suspected Reprotoxic Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
245-366-4 | 22984-54-9 | Italy | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Not started | Details | ||
218-747-8 | 2224-33-1 | Italy | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Not started | Details | ||
201-159-0 | 78-93-3 | 2018 | Sweden | Suspected Reprotoxic Potential endocrine disruptor Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use | Ongoing | Details | |
202-496-6 | 96-29-7 | 2013 | Germany | CMR Sensitiser Consumer use Cumulative exposure High RCR Wide dispersive use | Concluded | Details | |
205-480-7 | 141-32-2 | 2013 | Sweden | Suspected CMR High (aggregated) tonnage Other exposure/risk based concern | Conclusion under preparation | Details | |
700-992-1 | - | 2014 | Norway | Suspected PBT/vPvB Consumer use High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
215-609-9 | 1333-86-4 | 2021 | France | Carcinogenic Suspected Reprotoxic Consumer use Cumulative exposure Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use | Not started | Details | |
200-843-6 | 75-15-0 | 2013 | France | CMR Potential endocrine disruptor Exposure of environment Exposure of workers High (aggregated) tonnage | Follow-up | Details | |
200-262-8 | 56-23-5 | 2012 | France | CMR Exposure of workers High (aggregated) tonnage | Conclusion under preparation | Details | |
215-150-4 | 1306-38-3 | 2020 | Germany | Suspected Carcinogenic Suspected Mutagenic Other hazard based concern Cumulative exposure Exposure of environment Wide dispersive use | Not started | Details | |
200-817-4 | 74-87-3 | 2012 | Italy | CMR Potential endocrine disruptor High RCR | Concluded | Details | |
215-160-9 | 1308-38-9 | 2019 | France | Suspected Reprotoxic Suspected Sensitiser High (aggregated) tonnage | Ongoing | Details | |
226-394-6 | 5392-40-5 | 2015 | Sweden | Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
203-376-6 | 106-23-0 | 2015 | Sweden | Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
253-775-4 | 38083-17-9 | 2014 | Belgium | Suspected CMR Consumer use Wide dispersive use | Information requested | Details | |
203-631-1 | 108-94-1 | 2016 | Poland | Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Exposure of workers High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
203-629-0 | 108-91-8 | 2016 | Belgium | Reprotoxic Exposure of environment High (aggregated) tonnage | Concluded | Details | |
201-248-4 | 80-08-0 | 2016 | Germany | Potential endocrine disruptor | Concluded | Details | |
202-046-9 | 91-17-8 | 2012 | Finland | Suspected PBT/vPvB High (aggregated) tonnage | Follow-up | Details | |
205-491-7 | 141-62-8 | 2015 | Norway | Suspected PBT/vPvB Exposure of environment Wide dispersive use | Follow-up | Details | |
203-956-9 | 112-30-1 | 2012 | Italy | Other hazard based concern High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use | Concluded | Details | |
229-782-3 | 6731-36-8 | 2014 | Germany | Suspected PBT/vPvB | Follow-up | Details | |
203-733-6 | 110-05-4 | 2016 | Netherlands | CMR Consumer use High (aggregated) tonnage Wide dispersive use | Ongoing | Details | |
234-042-8 | 10508-09-5 | 2015 | Italy | Suspected Carcinogenic Suspected Mutagenic Exposure of workers Wide dispersive use | Follow-up | Details | |
205-016-3 | 131-17-9 | 2013 | Spain | CMR Consumer use Wide dispersive use | Concluded | Details | |
215-175-0 | 1309-64-4 | 2018 | Germany | Carcinogenic Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use | Ongoing | Details | |
200-901-0 | 75-78-5 | 2014 | Czech Republic | Suspected PBT/vPvB High (aggregated) tonnage | Concluded | Details | |
200-838-9 | 75-09-2 | 2016 | Italy | Carcinogenic Suspected Mutagenic Suspected Reprotoxic Potential endocrine disruptor Suspected Sensitiser High (aggregated) tonnage | Ongoing | Details | |
DCHP | 201-545-9 | 84-61-7 | 2017 | Sweden | Potential endocrine disruptor Exposure of environment Wide dispersive use | Information requested | Details |
200-467-2 | 60-29-7 | 2020 | France | Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Other hazard based concern Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use | Not started | Details | |
201-550-6 | 84-66-2 | 2014 | Germany | CMR Potential endocrine disruptor Consumer use High (aggregated) tonnage Wide dispersive use | Concluded | Details | |
Categories Display
Route: .live2